| Analysis | Metabolite Name | Measured Value | Units | Group | Treatment | Sample Source |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | Histamine | 0.0211 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0294 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0301 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0338 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0405 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0413 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0421 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0422 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0424 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0477 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0479 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0484 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0497 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0509 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.05115 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0529 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0538 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0571 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0586 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0593 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0604 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0608 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0625 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0728 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0788 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0789 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0861 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.0878 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.102 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.111 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | Histamine | 0.2 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.2 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.2 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.3 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.3 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.3 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.3 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.3 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.4 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.4 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.4 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | Histamine | 0.4 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|